AIFinancial Timesabout 2 hours ago
Viva Biotech 2026 Interim Results: AI Drives Drug R&D
1 min read
Viva Biotech announced its 2026 interim results, reporting that AI sparks a new paradigm in drug R&D. The company's CDMO commercial manufacturing accelerates revenue growth, according to the company announcement.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
